title: [Letter to the editor].
authors: N
authors: N
authors: Román González
authors: A
authors: A
authors: Quintana Holgado
authors: M P
authors: MP
authors: Himénez Hernández
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D055118:Medication Adherence; D000068882:Paliperidone Palmitate; D010168:Palmitates / Q000627:therapeutic use*; D011355:Prodrugs / Q000627:therapeutic use*; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D007555:Isoxazoles; D010168:Palmitates; D011355:Prodrugs; D018967:Risperidone; D000068882:Paliperidone Palmitate